Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Long-term Safety Trial with NVDX3 — Stella

Home/Distal Radius Fractures/Long-term Safety Trial with NVDX3

View on ClinicalTrials.gov

Recruiting

Back to Distal Radius Fractures trials

Long-term Safety Trial with NVDX3

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

Luxembourg

Centre Hospitalier de Luxembourg, Luxembourg

Key details

Phase

Early testing / Safety & dosing

Sponsor

Novadip Biosciences

Collaborators

PrimeVigilance, Data Investigation Company Europe (DICE)

Enrollment target

~15 participants

Started

August 2024

Primary completion

March 2036

Age range

18 Years and older

Last updated September 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.